Navigation Links
Med-Emerg International Inc. obtains interim court order for plan of arrangement with AIM Health Group Inc.
Date:11/21/2008

Special meeting of shareholders to be held on January 8, 2009

TORONTO, Nov. 21 /PRNewswire-FirstCall/ - Med-Emerg International Inc. ("MedEmerg") (OTCBB: MDER), one of Canada's leading providers of health services, announced today that it has obtained an interim order from the Ontario Superior Court of Justice concerning its previously announced plan of arrangement (the "Arrangement") pursuant to which AIM Health Group Inc. ("AIM") will acquire all of MedEmerg's outstanding shares. Under the Arrangement, holders of MedEmerg common shares will receive 0.78091 of an AIM common share for each MedEmerg common share, subject to adjustment in the case of fractional AIM common shares and Calian Technologies Ltd., the sole holder of Special Shares, Series 1 of MedEmerg, will exchange all of such shares for a secured convertible debenture of AIM. In addition, MedEmerg options will be exchanged for AIM options and MedEmerg warrants will be cancelled.

A special meeting of shareholders, called to approve the Arrangement, will be held on January 8, 2009. Shareholders of record on November 24, 2008 will be entitled to receive notice and vote at the special meeting. MedEmerg will mail a management information circular and related meeting materials to shareholders in connection with the special meeting next week. These documents will be filed under MedEmerg's company profile on SEDAR at www.sedar.com.

The Board of Directors of MedEmerg has recommended that MedEmerg shareholders vote in favour of the Arrangement.

About Med-Emerg International Inc.

MedEmerg specializes in the coordination and delivery of health care services in Canada. These services include an integrated chronic pain management program, community-based infusion centers and health human resource management, including physician and nurse staffing.

Med-Emerg's audited revenue for its fiscal year ended December 31, 2007 was approximately US$22 million.

(www.medemerg.com)

Caution Concerning Forward-Looking Statements

Certain statements in this press release are forward-looking statements, including, but not limited to, the timing of the special meeting of shareholders and other statements that are not historical facts. These statements are based upon certain material factors, assumptions and analyses that were applied in drawing a conclusion or making a forecast or projection, including MedEmerg's experience and perceptions of historical trends, current conditions and expected future developments, as well as other factors that are believed to be appropriate in the circumstances. Forward-looking statements are provided for the purpose of presenting information about management's current expectations and plans relating to the future and readers are cautioned that such statements may not be appropriate for other purposes. Forward-looking statements include statements that are predictive in nature, depend upon or refer to future events or conditions, or include words such as "expects", "anticipates", "plans", "believes", "estimates", "intends", "targets", "projects", "forecasts", "seeks", "likely" or negative versions thereof and other similar expressions, or future or conditional verbs such as "may", "will", "should", "would" and "could".

By its nature, this information is subject to inherent risks and uncertainties that may be general or specific and which give rise to the possibility that expectations, forecasts, predictions, projections or conclusion will not prove to be accurate, that assumptions may not be correct and that objectives, strategic goals and priorities will not be achieved. A variety of material factors, many of which are beyond MedEmerg's control, affect operations, performance, achievements and results of MedEmerg that may be expressed or implied by such forward-looking statements and could cause actual results to differ materially from current expectations of estimated or anticipated events or results.

These forward-looking statements are made as of the date of this release and, other than as specifically required by law, MedEmerg assumes no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which such statement is made, or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Additional information about the risks and uncertainties of MedEmerg's business is provided in its disclosure materials filed with the securities regulatory authorities in Canada, available at www.sedar.com.


'/>"/>
SOURCE Med-Emerg International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Med-Emerg International Inc. reports improved income from continuing operations
2. Permanent International Healthcare Marketplace and Education Center Set to Open in New York City in 2013
3. Epocrates Offers International Market Research Panel
4. Accreditation to the International Standards Organization for Quality Management Granted to First U.S. Lab
5. MINRAD International, Inc. to Discuss Current Business Conditions on Tuesday, November 25, 2008
6. Lilly and International Council of Nurses Win Partnership Award From the U.S. Chamber of Commerce Business Civic Leadership Center
7. UIC joins international research effort to study autism
8. Service Corporation International Increases Share Repurchase Authorization to $150 Million and Declares Quarterly Cash Dividend
9. AACR to host 7th Annual International Conference on Frontiers in Cancer Prevention Research
10. Anthem Blue Cross and Blue Shield Introduces International Medical Tourism Pilot Program
11. Lilly Announces Major Donation of Insulin to International Diabetes Federations Life for a Child Program; Initial Focus Will Be on Sub-Saharan Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... ... January 19, 2017 , ... Dr. ... Board of Dermatology and fellowship trained Mohs and cosmetic surgeon. After extensive dermatology ... Dr. Li completed his internship in internal medicine at the Emory University and ...
(Date:1/19/2017)... , ... January 19, 2017 , ... ... now offering treatments for patients with sleep apnea and TMJ disorders. These conditions ... and physical health. Dr. Rassouli provides personalized care to reduce the risk of ...
(Date:1/19/2017)... ... January 19, 2017 , ... Rountree ... planning services to communities throughout eastern Georgia, is embarking on a charity effort ... Heart disease kills more Americans every year than anything else, yet risk factors ...
(Date:1/19/2017)... ... January 19, 2017 , ... Creative messages ... Real Impact contest from Impact Teen Drivers and California Casualty. Entries from students ... , Educational grants totaling $15,000 will be awarded for the best peer-to-peer messages ...
(Date:1/19/2017)... ... , ... The 21st Century Cures Act’s Impact on Medical Devices:, What You ... 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/21stcenturycures          , What do ... this year? , The passage of the act means devicemakers will be scrambling to ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... -- Accuray Incorporated (Nasdaq: ARAY ) announced ... set the bar for excellence in customer satisfaction. The ... rating among radiation treatment delivery systems in the U.S., ... Briefing™. The most recent ratings trend also shows Accuray ... for 11 of the past 12 quarters. ...
(Date:1/19/2017)... 19, 2017 Shire plc (LSE: ... U.S. Food and Drug Administration (FDA) has acknowledged receipt ... Application (NDA) for SHP465, a long-acting, triple-bead, mixed amphetamine ... once-daily treatment for Attention-Deficit/Hyperactivity Disorder (ADHD). The FDA is ... 20, 2017, the designated Prescription Drug User Fee Act ...
(Date:1/19/2017)... The global  pacemaker market  is expected to reach USD ... Inc. The heightening prevalence of cardiac conditions coupled with the availability of medical ... addition, technological enhancements in these devices are supporting the expansion of this vertical. ... ... Grand View Research Logo ...
Breaking Medicine Technology: